Mark Johnson joins The RSA Group as Partner
London, UK, 6th February 2019 / Sciad Newswire / The RSA Group, a leading Life Sciences executive search firm, announced today that Mark Johnson has joined the company as a Partner. Mark is a respected life sciences search professional with particular expertise in the cell and gene therapy sector.
Mark has significant experience across medical, manufacturing and supply chain, commercial, R&D, CMC, Clinical Operations, Regulatory and Programme / Project Leader recruitment. This stems from an early career in biologics development, manufacturing and quality at MedImmune and Novartis. Most recently he has focused on cell and gene therapy and joins The RSA Group as an expert in this field.
Nick Stephens, Executive Chairman of The RSA Group, commented: “I am delighted to welcome Mark to the RSA team, bringing a wealth of experience building leadership teams across the biotech and pharmaceutical industries globally.”
Mark Johnson added, “I’m very pleased to join The RSA Group and look forward to working closely with the team to connect our global clients with the best talent from both the cell and gene therapy sector, and across the life sciences industry.”
For further information, contact:
Sciad Communications, Media Relations
Emma Pickup, Junior Account Manager
T: +44 (0)20 7470 8801
Notes to Editors
About The RSA Group
The RSA Group is the pre-eminent executive search firm in global Life Sciences. Providing a unique combination of executive search and executive interims, we deliver results through data-driven due diligence. Our Proof of Candidate® approach is based on evidence and in-depth comparative analysis, supporting clients to make better hiring decisions. Since 1981, our consultants have drawn on their wealth of executive search and industry experience to deliver a focused solution to our clients. Large enough to be global and small enough to remain local, we are where you are, with locations in the UK, USA, China, Germany, Singapore, Switzerland, and Turkey. To learn more about The RSA Group, visit www.theRSAgroup.com